SHERRY SHIRE-MISNIK: Open Payments
NPI 1770721433 · TREVOSE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,423 in 105 payments from 21 companies in 2025. Trend: 2023 $1,149 · 2024 $2,366 · 2025 $2,423
Food & beverage: $2,423
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $327 |
| Amgen Inc. | 9 | $307 |
| ABBVIE INC. | 12 | $304 |
| Lilly USA, LLC | 8 | $249 |
| Novo Nordisk Inc | 14 | $232 |
| PFIZER INC. | 8 | $165 |
| Exact Sciences Corporation | 8 | $135 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $124 |
| Janssen Pharmaceuticals, Inc | 5 | $118 |
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
Products named: VRAYLAR, OTEZLA, PREVNAR 20, REXULTI, REPATHA, AIRSUPRA, CAPLYTA, ZEPBOUND.
Industry payments across PA — which companies pay providers there.
